Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2010
09/16/2010US20100233151 Compositions and methods for treating collagen-mediated diseases
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010CA2755198A1 Ox40/trail fusion proteins
09/16/2010CA2755109A1 Sparc angiogenic domain and methods of use
09/16/2010CA2754851A1 Method for improving the yield of a polypeptide
09/16/2010CA2754591A1 Generation, expression and characterization of the humanized k33n monoclonal antibody
09/16/2010CA2754387A1 Pregastric esterase and derivatives thereof
09/15/2010EP2228450A1 Taurine transporter gene
09/15/2010EP2228448A1 MU-1 member of the cytokine receptor family
09/15/2010EP2228445A1 Fucose Transporter
09/15/2010EP2228440A1 Variants of beta-glucosidases
09/15/2010EP2228392A1 Monoclonal antibody capable of binding to anexelekto, and use thereof
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228379A1 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
09/15/2010EP2227553A2 Lac expression system
09/15/2010EP1673387B1 Il-21 derivatives
09/15/2010EP1450857B1 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes
09/15/2010EP1430140B1 N-terminally truncated isoforms of pde3a cyclic phosphodiesterases
09/15/2010CN1752211B Recombination target fused protein for treating acquired immunodeficiency syndrome
09/15/2010CN101835897A Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin
09/15/2010CN101835796A Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
09/15/2010CN101835791A Protein purification method
09/15/2010CN101831481A New method for preparing Iturin A and homolugues thereof
09/15/2010CN101831480A Staphylococcal enterotoxin C3 preparation, formulation, dosage and application thereof
09/15/2010CN101831441A Escherichia coli engineering bacteria for expressing recombinant CrylC genes
09/15/2010CN101831411A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
09/15/2010CN101830974A Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof
09/15/2010CN101830967A Oligopeptide with angiotensin transferase inhibiting activity and preparation method thereof
09/15/2010CN101829324A Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody
09/15/2010CN101297675B Industrial process for producing wheat peptide from glutelin powder by enzyme method
09/15/2010CN101012472B Method for preparation of egg white oligopeptide having high F value
09/14/2010US7795504 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795413 Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
09/14/2010US7795412 encodes polypeptide that is an epitope tag or a Fc region of an immunoglobulin; used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
09/14/2010US7795411 Expression vector comprising yeast secretory leader sequence, biotin acceptor site for golgi-localized biotin ligase and yeast replication origin for use as tool in expression of heterologous gene sequences in yeast cells
09/14/2010US7795408 Method for cloning and expression of Acc65I restriction endonuclease and Acc65I methylase in E. Coli
09/14/2010US7795402 comprises an antibody is enriched for immunoglobulins having both an antigen-binding portion that binds a Staphylococcus aureus capsular polysaccharide antigen and a constant region that does not bind staphylococcal protein A
09/14/2010US7795396 COOH-terminally added cysteine variant of the beta interferon
09/14/2010US7795394 Saitohin gene and uses of same
09/14/2010US7795392 Organic anion transport proteins
09/14/2010US7795391 Protein showing enhanced expression in cancer cells
09/14/2010US7795388 circularly permuted chaperonin peptide molecule, comprising a new carboxyl-terminal amino acid and a new amino-terminal amino acid and a reordered chaperonin polypeptide sequence; can assemble into double-ringed chaperonin structures which can organize into higher order structures such as nanofilaments
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795384 expressed with high efficiency and stability in host cells; suitable for high effectively producing short peptides without lysine residues; digesting the fusion protein with trypsinase and carboxypeptidase B, thereby forming peptides C1 and C2
09/14/2010US7795381 Helper T lymphocytes epitope for use in induction of antitumor responses in melanoma; antiproliferative agents
09/14/2010US7794996 Viral polymerase with enhanced activity and specificity; gene expression analysis; CDNA libraries
09/14/2010US7794995 use of several sequential steps, including subcellular fractionation to isolate a plasma membrane fraction and the use of gel filtration or chromatography that separates molecules according to their size or affinity; drug screening
09/14/2010US7794994 Enzyme-based system and sensor for measuring acetone
09/14/2010US7794993 Carbonyl reductase, gene thereof and method of using the same
09/14/2010US7794981 Prosuction of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae
09/14/2010US7794980 comprising an autoprocessing segment having an amino acid sequence being capable of auto-cleavage
09/14/2010US7794979 for generation of insoluble fusion peptides; used for the expression and recovery of any bioactive peptides and proteins that are recombinantly expressed
09/14/2010US7794978 Cells comprise orthogonal aminoacyl-tRNA synthetase and p-acetyl-L-phenylalanine; site-directed mutagenesis; kits
09/14/2010US7794977 Using transgenic cell comprising stabilizing-antirepression sequences (STAR) a bioreactor for production of preferential polypeptides
09/14/2010US7794976 Using expression vector comprising 3' untranslated region of immunoglobulin light chain and an epstein-barr viral origin of replication as gene transfer vehicle for expression of heterologus gene sequences in cells
09/14/2010US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
09/14/2010US7794974 Fungal transcriptional activators useful in methods for producing a polypeptide
09/14/2010US7794972 Benzoate-and anthranilate-inducible promoters
09/14/2010US7794928 Norovirus detection, methods and compositions therefor
09/14/2010US7794726 based on a native version of the enzyme from E. corrodens and induces production of antibodies that inhibit the activity of the lysine decarboxylase enzyme in the oral cavity; comprising a substitution at a position corresponding to position 365 of SEQ ID NO:2
09/14/2010US7794719 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
09/14/2010US7794718 fusion protein comprising polypeptide with a human immunoglobulin (Ig) polypeptide; has an ability to bind CD80 or CD86 or an extracellular domain of either CD80 or CD86, and/or an ability to inhibit a T cell immune response
09/14/2010CA2370393C Dna sequence, and recombinant production of a gramineae allergen
09/14/2010CA2322792C Polypeptides homologous to vegf and bmp1
09/14/2010CA2259492C Biological production of acetic acid from waste gases
09/14/2010CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth
09/14/2010CA2195970C Production of collagen in the milk of transgenic mammals
09/14/2010CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
09/10/2010WO2010101256A1 Thermotolerant transglutaminase originating in actinomyces
09/10/2010WO2010101129A1 Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factors
09/10/2010WO2010100239A1 Enzyme-based fed-batch technique in liquid cultures
09/10/2010WO2010099612A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010WO2010065077A3 Antagonists of il-6 to prevent or treat thrombosis
09/10/2010WO2010058427A3 Process for production and purification of polymyxin b sulfate
09/10/2010CA2753621A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010CA2752262A1 Enzyme-based fed-batch technique in liquid cultures
09/09/2010US20100228007 Mhc-peptide complex binding ligands
09/09/2010US20100227819 Serum-Free Cell Culture Medium for Mammalian Cells
09/09/2010US20100227802 Methods and materials relating to PAQR polypeptides and polynucleotides
09/09/2010US20100227364 Novel Lipolytic Enzyme ELIP
09/09/2010US20100227363 Alg3 mutant
09/09/2010US20100227362 Novel YLMPO1 Gene Derived From Yarrowia Lipolytica and A Process for Preparing a Glycoprotein Not Being Mannosylphosphorylated By Using a Mutated Yarrowia Lipolytica in Which YLMPO1 Gene is Disrupted
09/09/2010US20100227361 Host cell modifications that improve peptide production and downstream processing
09/09/2010US20100227343 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer
09/09/2010US20100227335 Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer
09/09/2010US20100226925 Homogeneous Antibody Populations
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/09/2010US20100226915 AGER-Peptides and Use Thereof
09/09/2010US20100226912 RECOMBINANT PROTEIN PRODUCTION IN AVIAN EBx® CELLS
09/09/2010US20100226884 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
09/08/2010EP2226635A1 Immunodetection assay for mycobacterium tuberculosis complex
09/08/2010EP2226385A1 Human Coagulation Factor VII Variants
09/08/2010EP2226381A1 Method for cultivating cells for the production of compounds
09/08/2010EP2226380A1 Enzyme-based fed-batch technique in liquid cultures
09/08/2010EP2225389A1 Sm-protein based secretion engineering
09/08/2010EP1478667B1 Anti-human tenascin monoclonal antibody
09/08/2010EP1429797B1 Diagnosis and treatment of malignant neoplasms